Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
Key Information
Due Date: April 3, 2026
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
It has been well-equipped to conduct preclinical services. Some of these include studies that enable Investigational Device Exemption (IDE) or Investigational New Drug (IND). These studies involve a wide range of processes such as protein generation, X-ray crystallography, high throughput screening, establishing structure-activity relationships, generating a hit-to-lead, and studying drug metabolism.
The overall aim of this facility is to ensure it can produce a preclinical candidate that is eligible for IND/IDE studies. The candidate must provide a safe therapeutic alternative in the realm of contraception and other areas connected to reproductive health. Provision of this service hinges on contractor availability and whether there is sufficient funding.
Key Dates
Open Date: May 19, 2023
Application Due Date: April 3, 2026
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses